Immune sensitivity links race and survival after prostate cancer immunotherapy

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup